Exane Derivatives’s Emcor EME Stock Holding History
Bought
Maintained
Sold
Other funds holding EME
Exane Derivatives's EME Position: Q2 2022 in Review
Exane Derivatives increased its Emcor (EME) stake by 7.7% in Q2 2022, buying an estimated $14.9K and bringing the position to 1,952 shares worth $201K. The position accounts for 0.12% of the portfolio, ranked #163.
Exane Derivatives first reported a position in EME in Q2 2021 and has held it in 5 quarters since. The position peaked at $571K in Q4 2021. 382 funds tracked by Wall St. Rank hold EME as of Q2 2022.
- Exane Derivatives held 1,952 shares of Emcor worth $201K as of Q2 2022.
- Exane Derivatives bought 139 Emcor shares in Q2 2022, an estimated $14.9K.
- Emcor made up 0.12% of Exane Derivatives's portfolio in Q2 2022, its #163 holding.
- Exane Derivatives first reported a position in Emcor in Q2 2021 and has held it in 5 quarters since.
- Exane Derivatives's Emcor position peaked at $571K in Q4 2021.
- 382 funds tracked by Wall St. Rank held Emcor as of Q2 2022.
Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.